extracellular.com

What It Is

Extracellular positions itself as a CDMO—contract development and manufacturing organization—for the sustainable bioeconomy, serving companies working with animal and plant cell technologies in non-medical biotechnology. Its focus areas include cultivated meat, plant cell culture, and bioactive substances. The core goal is to help customers move from R&D into process scale-up and commercial production. Strictly speaking, it is not a typical SaaS or enterprise software product, and some Pricing page content captured from the site appears clearly inconsistent with its main business.

Core Features and Capabilities

The main modules disclosed on the website include contract manufacturing, process development, media development, cell line development, and consulting services. Its manufacturing capacity goes up to 2,000L, with an emphasis on commercial production, supply of evaluation materials, and scalability validation. Process development supports parallel bioreactors, high-throughput optimization, process intensification, as well as continuous, semi-continuous, and fed-batch workflows. Media development focuses on high-throughput screening, replacing animal serum components, cost optimization, and stability studies. Consulting services cover technology assessment, manufacturability, COGS modeling, technology roadmapping, and due diligence support.

Pricing and Compliance

Specific pricing for its core CDMO services is not publicly disclosed and would typically be customized based on project scope, scale, materials, quality systems, and delivery objectives. The captured Pricing page lists a free Hobby plan, a Pro plan at $20 per month, and a custom Enterprise plan, with features such as bandwidth, deployments, and Edge functions. This does not align with Extracellular’s biomanufacturing business and is likely leftover template content or an unrelated page, so it should not be used as a basis for procurement quotes. On the compliance side, the website lists ISO 22000, ISO 9001:2015, an FSA-registered food production facility, Cyber Essentials Plus, and HACCP compliance, which are meaningful credibility signals.

Pros, Cons, and Best Fit

Its strengths are a relatively complete chain from R&D to scale-up, a team with experience in biomanufacturing, GMP production, and project operations, plus operational indicators such as 35+ projects, 20+ global customers, and a 9,000-square-foot facility. The limitations are that pricing, capacity scheduling, sample logistics, quality agreement details, and regional service capabilities are not disclosed. SaaS-related dimensions such as APIs, third-party integrations, and permission systems are largely not applicable. It is best suited to biotech teams that need cell culture process development, media cost reduction, scale-up validation within 2,000L, or pre-commercial manufacturing consulting.

Access from China and Alternatives

Access from China is unclear, and the available text does not state whether Extracellular has a local China team, RMB payment support, cross-border sample shipping support, or regulatory assistance. Chinese customers considering procurement should focus on confirming online communication reliability, contract payment methods, sample import/export arrangements, and compliance requirements for food or biological materials. Alternatives may include local biomanufacturing CDMOs, pilot-scale scale-up platforms, or process development organizations specializing in cellular agriculture.